Cite

HARVARD Citation

    Muqbil, I. et al. (2019). Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model. Heliyon. 5 (8), p. . [Online]. 
  
Back to record